Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial

Fig. 2

Graphs with the change from baseline and after 16 weeks of treatment with the CNIC-polypill strategy or usual care for LDL-c (A) and systolic blood pressure (C) and estimated mean difference between treatments for LDL-c (B) and systolic blood pressure and (D). LDL-c low-density lipoprotein; LSM least square mean; SBP systolic blood pressure

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us